Automated Breast Ultrasound System Market (ABUS) by Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner), Device Type (Portable, Standalone), Application, End User - Global Forecast 2024-2030

Automated Breast Ultrasound System Market (ABUS) by Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner), Device Type (Portable, Standalone), Application, End User - Global Forecast 2024-2030

The Automated Breast Ultrasound System Market size was estimated at USD 2.23 billion in 2023 and expected to reach USD 2.47 billion in 2024, at a CAGR 11.34% to reach USD 4.74 billion by 2030.

An automated breast ultrasound system (ABUS) is a non-invasive medical imaging technology designed to produce three-dimensional (3D) images of breast tissue. It is primarily used as a supplementary breast cancer screening tool, especially in women with dense breast tissue where traditional mammograms may not be as effective. Unlike manual ultrasound or mammography, ABUS scans the entire breast with minimal operator involvement, enhancing the detection capabilities for breast cancer. There is a growing awareness among populations about the need for early breast cancer identification, which has led to an increase in screenings. ABUS, providing detailed images, caters to this need efficiently, especially in dense breast tissues where mammograms might not be sufficient. Several governments globally are implementing programs and policies to facilitate the early diagnosis of breast cancer, including funding for advanced screening technologies such as ABUS. However, in some regions, there are insufficient insurance and reimbursement models for ABUS screenings, which can dissuade facilities from adopting the technology and patients from opting for the procedure. The interpretation of ABUS images can be challenging due to the volume of data and intricacies in visualizing abnormalities, requiring specialized training. However, the use of AI/ML for analyzing ABUS images could significantly improve the accuracy of breast cancer screenings and diagnostics, reducing the dependency on manual interpretation. Future developments aimed at making ABUS devices more portable and user-friendly can open new avenues for its use in remote or underserved areas, improving breast cancer screening rates.

Regional Insights

The Americas region, particularly the United States and Canada, provides a highly developed landscape for the adoption of ABUS due to high patient awareness regarding advanced healthcare technologies, robust healthcare infrastructure, and significant investments in healthcare. There's a noticeable trend towards personalized healthcare, influencing patient and medical professional's focus toward advanced diagnostic solutions such as ABUS. Recent patents in the U.S. focus on enhancing the resolution and reducing the time taken for breast imaging, indicating a push towards more efficient and patient-friendly technologies. The EU countries present a mature market for ABUS, with a strong emphasis on cancer screening programs and widespread adoption of advanced medical technologies. Consumer behavior in Europe is significantly influenced by extensive healthcare policies and support systems, leading to higher need for innovative, non-invasive diagnostic methods. The presence of stringent regulations for the performance, safety, and privacy compliance of medical devices and systems has provided a conducive framework for innovations in ABUS. Ongoing research in the EU is inclined towards integrating artificial intelligence with ABUS to improve diagnostic accuracy, reflecting the region's commitment to incorporating cutting-edge technology in healthcare. In the Middle East, the Gulf Cooperation Council (GCC) countries, particularly, are investing heavily in healthcare and showing interest in the latest medical technologies, providing opportunities for the growth and adoption of ABUS. APAC is experiencing a crucial need for ABUS due to its large population and governmental emphasis on healthcare reform. Innovative breast cancer screening initiatives and local companies' efforts to develop affordable ABUS technologies are notable trends. Japan has a sophisticated healthcare system and high healthcare expenditure, combined with an aging population that needs high-quality medical care.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Automated Breast Ultrasound System Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Rising prevalence of breast cancer across the globe
• Growing need for early diagnosis in breast cancer
• Favorable government support for breast cancer treatment

Market Restraints

• High cost of advanced ultrasound systems and lack of skilled professional

Market Opportunities

• Extensive R&D for upgraded imaging techniques and government advocate towards breast cancer awareness
• AI integration with ABUS to improve diagnostic accuracy and efficiency

Market Challenges

• Regulatory and reimbursement issues and technical complexities

Market Segmentation Analysis

• Product: Crucial role of automated breast ultrasound system in the early detection and diagnosis of breast cancer
• Application: Adoption of advanced automated technologies to facilitate screening of women with dense breast tissue

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Automated Breast Ultrasound System Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Automated Breast Ultrasound System Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Strategic Alliance Enhances Global Breast Cancer Screening with AI-Driven Technology

Molbio Diagnostics has strategically partnered with Niramai Health Analytix to expand the global reach of an innovative AI-enabled breast cancer screening methodology, Thermalytix. This advanced solution merges thermal imaging with artificial intelligence to offer a non-invasive, efficient, and early detection system for breast cancer, aiming to overcome limitations inherent in traditional screening methods.

Strategic Alliance between Medicom Technologies Inc. and Onsite Women's Health Improves Breast Cancer Detection

Medicom Technologies Inc. entered into a strategic partnership with Onsite Women's Health, aiming to enhance the patient and clinician experience in breast cancer detection. This collaboration combines Medicom's expertise in medical image exchange with Onsite's comprehensive breast imaging services, including 3D mammography and automated breast ultrasounds, to offer significant improvements in the early detection and treatment of breast cancer. These entities are poised to make a meaningful impact on improving outcomes for individuals facing breast cancer challenges by leveraging advanced technology and a patient-centric approach.

Introduction of Advanced Breast Cancer Screening for Women with Dense Breast Tissue at Baptist Health Fort Smith

Baptist Health Breast Center in Fort Smith aims to enhance breast cancer screening capabilities for women with dense breast tissue through the adoption of the Invenia ABUS 2.0 System. This automated breast ultrasound system, used in conjunction with mammography, significantly improves the detection of breast cancer in asymptomatic women with dense breasts, with a 35.7 percent increase in cancer identification rates for those without previous breast interventions.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Automated Breast Ultrasound System Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Automated Breast Ultrasound System Market, highlighting leading vendors and their innovative profiles. These include ALPINION Medical Systems Co., Ltd., BK Medical Holding Company, Inc., Canon Medical Systems Corporation, Carestream Health, Inc., Delphinus Medical Technologies, Inc., Esaote S.p.A, Fujifilm Holdings Corporation, Fukuda Denshi Co., Ltd., GE Healthcare, Hologic, Inc, Konica Minolta, Inc., Medicom Technologies Inc., Micrima Ltd., Mindray Medical International Limited, Molbio Diagnostics, Philips Healthcare, Planmed Oy, QView Medical, Samsung Medison Co., Ltd, Siemens Healthineers, SonoCine, Inc., and Toshiba Corporation.

Market Segmentation & Coverage

This research report categorizes the Automated Breast Ultrasound System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
• Automated Breast Ultrasound System
• Automated Breast Volume Scanner
• Device Type
• Portable
• Standalone
• Application
• Diagnostics
• Screening
• End User
• Diagnostic Centers
• Hospitals
• Research Institutes
• Region
• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year